GB Patent

GB0107383D0 — Lipid profile modulation

Assigned to University of Edinburgh · Expires 2001-05-16 · 25y expired

What this patent protects

The invention provides use of an agent which lowers levels of 11beta-HSD1 in the manufacture of a composition for the promotion of an atheroprotective lipid profile.

USPTO Abstract

The invention provides use of an agent which lowers levels of 11beta-HSD1 in the manufacture of a composition for the promotion of an atheroprotective lipid profile.

Drugs covered by this patent

Patent Metadata

Patent number
GB0107383D0
Jurisdiction
GB
Classification
—
Expires
2001-05-16
Drug substance claim
No
Drug product claim
No
Assignee
University of Edinburgh
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.